Solutions for the Next Generation of Novel Therapies


AMPEL BioSolutions is the leading biomedical research think tank that creatively addresses clinical development bottlenecks and R&D roadblocks. AMPEL interrogates, analyzes, synthesizes & interprets the world’s biomedical knowledge to provide novel solutions for clinical research questions.

  • Resourceful and dedicated, AMPEL is composed of leading experts in autoimmunity, immunogenicity, inflammation and clinical immunology with extensive research and medical experience to address and resolve obstacles.
  • AMPEL assists nonprofit organizations, pharmaceutical companies, clinical research groups, and others in basic research, translational medicine, preclinical research, drug development and repositioning, and biomarker identification.


ImmunArray Enters Partnership with Kindstar Global

ImmunArray, a privately held molecular device company dedicated to the development of novel, blood-based in vitro diagnostic tests,…

read more

A Sister’s Story: New Hope in Her Twin’s Cruel Struggle With Lupus

AMPEL Biosolutions was recently mentioned in an article written by Kirsten (Gee) Maeda, co-founder of The GEE Twins…

read more

Dr. Amrie Grammer Joins Wendy Edwards To Talk About Lupus

Ampel BioSolutions co-founder Amrie Grammer talks with Wendy Edwards on Newsradio WINA joins to talk about Lupus.

read more